EHR Alert + Structured Communication for Pneumonia
(UP-CAPTAIn Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to improve antibiotic use in patients hospitalized with suspected pneumonia. It tests an alert system within electronic health records to guide testing and treatment. Some patients will receive structured communication of test results to help reduce unnecessary antibiotics if their tests suggest a viral infection. This trial may suit those hospitalized with a suspected respiratory infection, already on antibiotics, but whose tests indicate a viral cause. As an unphased trial, it offers a unique opportunity to contribute to improving antibiotic practices in hospitals.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study focuses on antibiotic use, you may need to adjust your antibiotic treatment based on the trial's findings.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on improving antibiotic use for pneumonia, so it's best to discuss your current medications with the trial team.
What prior data suggests that this protocol is safe for improving antibiotic use in pneumonia patients?
Research has shown that electronic alerts with clear communication can improve antibiotic use in hospitals. Studies have found that these systems reduce unnecessary antibiotic use by advising doctors when to stop or reduce the dose. Patients generally accept this approach because it changes how doctors receive information rather than introducing new medications or treatments.
In one study, a similar system shortened the time patients were on antibiotics without causing harm. The goal is to ensure antibiotics are used only when necessary, helping to prevent resistance and keep patients safe. Various hospitals have successfully used this type of system, proving it is generally safe and effective for managing infections like pneumonia.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how electronic health record (EHR) alerts combined with structured communication can optimize pneumonia treatment. Traditional treatments often rely on the clinician’s discretion for interpreting test results and deciding on antibiotics. This trial introduces an EHR alert system that not only guides diagnostic testing but also communicates test results along with recommendations for when to consider adjusting antibiotic use. This approach aims to refine antibiotic usage, potentially reducing unnecessary prescriptions and combating antibiotic resistance. By enhancing communication and decision-making, the trial could lead to more effective and responsible pneumonia care.
What evidence suggests that this trial's treatments could be effective for pneumonia?
Studies have shown that electronic alerts can help hospitals use antibiotics more effectively. Research indicates that these alerts can shorten the duration of antibiotic use, preventing overuse. In this trial, one group will receive an electronic alert combined with structured communication of test results, which studies have shown helps doctors decide when to stop or change antibiotics for pneumonia patients. Another group will receive only the electronic alert without structured communication. Previous research suggests that combining alerts with advice from a team focused on smart antibiotic use can enhance decision-making about stopping or changing treatments. Therefore, using an alert system with clear communication might improve antibiotic use for patients suspected of having pneumonia.13678
Who Is on the Research Team?
Daniel J. Morgan, MD, MS
Principal Investigator
University of Maryland, Baltimore
Are You a Good Fit for This Trial?
This trial is for adult patients at two Maryland medical centers who are hospitalized with suspected community-acquired respiratory infections and have test results that may indicate a viral infection. They must be on antibiotics and not just have cold symptoms.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Randomization and Intervention
Patients with test results suggesting viral infection are randomized to receive either structured communication from the antimicrobial stewardship team or usual care.
Follow-up
Participants are monitored for safety outcomes including length of stay, readmissions, hospital-free days, and mortality.
What Are the Treatments Tested in This Trial?
Interventions
- Electronic alert
- Structured communication of test results
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jonathan Baghdadi
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator